《Human Psychopharmacology-clinical And Experimental》重点专注发布精神病学-医学领域的新研究,旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。该杂志创刊至今,在精神病学-医学领域,有较高影响力,对来稿文章质量要求较高,稿件投稿过审难度较大。欢迎广大同领域研究者投稿该杂志。
CiteScore | SJR | SNIP | CiteScore排名 | |||
---|---|---|---|---|---|---|
4.1 | 0.541 | 0.644 | 学科类别 | 分区 | 排名 | 百分位 |
大类:大类:Medicine
小类:小类:PsychiatryandMentalHealth
|
Q2 | 237/567 | 58% | |||
大类:大类:Medicine
小类:小类:Pharmacology(medical)
|
Q2 | 120/272 | 55% | |||
大类:大类:Medicine
小类:小类:Neurology(clinical)
|
Q2 | 192/400 | 52% | |||
大类:大类:Medicine
小类:小类:Neurology
|
Q3 | 100/192 | 48% |
按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
---|---|---|---|---|
学科:CLINICAL NEUROLOGY | SCIE | Q3 | 188 / 277 | 32.3% |
学科:PHARMACOLOGY & PHARMACY | SCIE | Q3 | 240 / 354 | 32.3% |
学科:PSYCHIATRY | SCIE | Q3 | 168 / 276 | 39.3% |
学科:PSYCHOLOGY | SCIE | Q3 | 49 / 92 | 47.3% |
按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
---|---|---|---|---|
学科:CLINICAL NEUROLOGY | SCIE | Q3 | 196 / 278 | 29.68% |
学科:PHARMACOLOGY & PHARMACY | SCIE | Q3 | 236 / 354 | 33.47% |
学科:PSYCHIATRY | SCIE | Q3 | 184 / 276 | 33.51% |
学科:PSYCHOLOGY | SCIE | Q3 | 67 / 92 | 27.72% |
文章名称
引用次数
Use of new and uncommon synthetic psychoactive drugs among a nationally representative sample in the United States, 2005-2017
7
Alcohol mixed with energy drink (AMED): A critical review and meta-analysis
7
Treatments used for obsessive-compulsive disorder-An international perspective
7
Memory and attention during an alcohol hangover
6
Thyroid structure and function in long-term lithium-treated and lithium-naive bipolar patients
5
Methamphetamine-associated psychosis: Clinical presentation, biological basis, and treatment options
5
The serotonin transporter and the activity regulated cytoskeleton-associated protein genes in antidepressant response and resistance: 5-HTTLPR and other variants
4
Medical aromatherapy revisited-Basic mechanisms, critique, and a new development
3
The relationship between the serotonin 2A receptor gene-1438A/G and 102T/C polymorphisms and citalopram/sertraline-induced nausea in major depressed patients
3
Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone palmitate and aripiprazole monohydrate
3
国家/地区
发文量
TUSA
36
TAustralia
19
TCHINA MAINLAND
15
TItaly
15
TEngland
14
TNetherlands
12
TJapan
9
TGERMANY (FED REP GER)
8
TCanada
7
TSpain
6





